<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01372709</url>
  </required_header>
  <id_info>
    <org_study_id>771-0008</org_study_id>
    <nct_id>NCT01372709</nct_id>
  </id_info>
  <brief_title>TriVascular Post-Market Registry</brief_title>
  <official_title>A Post-Market Study to Evaluate the Safety and Performance of the Ovation™ or Ovation Prime™ Abdominal Stent Graft System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>TriVascular, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Endologix</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective observational post-market study of subjects receiving the Ovation™ or&#xD;
      Ovation Prime™ Abdominal Stent Graft System (&quot;Ovation™ or Ovation Prime™ Abdominal Stent&#xD;
      Graft System Post-Market Study&quot;) in the treatment of abdominal aortic aneurysms (AAA). The&#xD;
      Ovation™ or Ovation Prime™ Abdominal Stent Graft System Post-Market study is intended to&#xD;
      expand the clinical knowledge base by collecting data on subjects treated with the Ovation™&#xD;
      or Ovation Prime™ Abdominal Stent Graft System in actual clinical practice following&#xD;
      commercial approval.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 2011</start_date>
  <completion_date type="Actual">June 14, 2019</completion_date>
  <primary_completion_date type="Actual">December 12, 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Treatment Success at 12 Months Post-Implantation/surgery.</measure>
    <time_frame>12 Months</time_frame>
    <description>The primary endpoint is treatment success at 12 months post-implantation/surgery. Treatment success is defined as a composite technical endpoint composed of successful introduction and deployment of the Ovation™ or Ovation Prime™ Abdominal Stent Graft System at the initial implantation procedure along with clinical endpoints of absence from type I or III endoleaks, aneurysm expansion, aneurysm rupture, conversion to open surgical repair, graft migration, and graft occlusion at 12 months post-implantation procedure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Safety and Performance Endpoints</measure>
    <time_frame>1, 6, &amp;12 Months</time_frame>
    <description>Freedom from type I and III endoleaks [1 &amp; 6 m, &amp; annual through 5 years]&#xD;
Freedom from aneurysm rupture [6 m, &amp; annual through 5 years]&#xD;
Freedom from aneurysm related mortality [1 month]&#xD;
Freedom from aneurysm expansion [6 m, &amp; annual through 5 years]&#xD;
Freedom from stent graft migration [6 m, &amp; annual through 5 years]&#xD;
Freedom from loss of device patency [1 &amp; 6 m, &amp; annual through 5 years]&#xD;
Freedom from aneurysm-related secondary endovascular procedures [1 &amp; 6 m, &amp; annual through 5 years]&#xD;
Freedom from device related adverse events [1 &amp; 6 m, &amp; annual through 5 years]</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">501</enrollment>
  <condition>Abdominal Aortic Aneurysm</condition>
  <arm_group>
    <arm_group_label>Ovation™ or Ovation Prime™ Abdominal Stent Graft System</arm_group_label>
    <description>Adult male and female patients will be consecutively screened for the study. Eligible patients must meet all of the inclusion criteria and none of the exclusion criteria.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ovation™ or Ovation Prime™ Abdominal Stent Graft System</intervention_name>
    <description>Single occurrence permanent implant of AAA device.</description>
    <arm_group_label>Ovation™ or Ovation Prime™ Abdominal Stent Graft System</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The Ovation™ or Ovation Prime™ Abdominal Stent Graft System study is a multicenter,&#xD;
        prospective, observational post-market study of subjects receiving the Ovation™ or Ovation&#xD;
        Prime™ Abdominal Stent Graft System for the treatment of abdominal aortic aneurysms (AAA).&#xD;
        The Ovation™ or Ovation Prime™ Abdominal Stent Graft System Post-Market Study intends to&#xD;
        expand the clinical evidence of the safety and performance of the Ovation™ or Ovation&#xD;
        Prime™ Abdominal Stent Graft System in an all comers (&quot;real world&quot;) patient population.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject is &gt; 18 years or minimum age as required by local regulations.&#xD;
&#xD;
          -  Indication for elective repair of AAA with an endovascular stent graft in accordance&#xD;
             with the Instructions for Use of the Ovation™ or Ovation Prime™ Abdominal Stent Graft&#xD;
             System.&#xD;
&#xD;
          -  Subject has signed an Ethics Committee (EC) approved Informed Consent Form. The&#xD;
             subject or legal representative has been informed of the nature of the study, has&#xD;
             consented to participate, and has authorized the collection and release of his/her&#xD;
             medical information.&#xD;
&#xD;
          -  Subject intends to electively receive the Ovation™ or Ovation Prime™ Abdominal Stent&#xD;
             Graft System.&#xD;
&#xD;
          -  Subject has the ability and willingness to comply with all follow-up exams as&#xD;
             indicated in clinical investigation plan.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject demonstrates high probability of non-adherence to physician's follow-up&#xD;
             requirements.&#xD;
&#xD;
          -  Subject's current participation in a concurrent randomized control trial (RCT) or&#xD;
             investigational device/drug study which could confound study results.&#xD;
&#xD;
          -  Life expectancy less than 1 year&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Subjects with poor renal function as indicated by a serum creatinine &gt; 2.5mg/dl.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Medical University of Vienna Dept. for Radiology, Section for Cardiovascular and Interventional Radiology</name>
      <address>
        <city>Wien</city>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>O.L. Vrouwziekenhuis</name>
      <address>
        <city>Aalst</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Imelda Ziekenhuis</name>
      <address>
        <city>Bonheiden</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Flanders Medical Research Program</name>
      <address>
        <city>Dendermonde</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universiteit Gent</name>
      <address>
        <city>Gent</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UZ Leuven</name>
      <address>
        <city>Leuven</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier Edouard Herriot</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hôpital Paul d'Egine</name>
      <address>
        <city>Paris</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Park Hospital Leipzig, Strümpellstr. 41</name>
      <address>
        <city>Leipzig</city>
        <state>Western Saxony Land</state>
        <zip>04289</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herz- und Gefässzentrum Bad Bevensen</name>
      <address>
        <city>Bad Bevensen</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Franziskus-Krankenhaus Berlin</name>
      <address>
        <city>Berlin</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Cardiovascular Center</name>
      <address>
        <city>Frankfurt</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitäres Herz und Gefaßzentrum Hamburg</name>
      <address>
        <city>Hamburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Städtisches klinikum Karlsruhe Klinik für Gefäß- und Thoraxchirurgie</name>
      <address>
        <city>Karlsruhe</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>&quot;CA Gefäßchirurgie Theresienkrankenhaus/St. Hedwig&quot;</name>
      <address>
        <city>Mannheim</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Attikon Hospital</name>
      <address>
        <city>Athens</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale San Raffaele</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Policlinico San Donato</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Civico Palermo</name>
      <address>
        <city>Palermo</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Bianchi Melacrino Morelli</name>
      <address>
        <city>Reggio Calabria</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Sant'Andrea</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale San Giovanni Addolorata</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Università La Sapienza/Policlinico Umberto I</name>
      <address>
        <city>Roma</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Univeristà La Sapienza/Policlinico Umberto I</name>
      <address>
        <city>Rome</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale San Giovanni Bosco</name>
      <address>
        <city>Torino</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>A.O. Ospedale di Circolo e Fondazione Macchi</name>
      <address>
        <city>Varese</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Södersjukhuset</name>
      <address>
        <city>Stockholm</city>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Frimley Park Hospital NHS Foundation Trust</name>
      <address>
        <city>Frimley</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. George's Vascular Institute</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Manchester Royal Infirmary</name>
      <address>
        <city>Manchester</city>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Belgium</country>
    <country>France</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Italy</country>
    <country>Sweden</country>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>http://www.trivascular.com/</url>
    <description>TriVascular Website</description>
  </link>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 10, 2011</study_first_submitted>
  <study_first_submitted_qc>June 10, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 14, 2011</study_first_posted>
  <last_update_submitted>June 3, 2021</last_update_submitted>
  <last_update_submitted_qc>June 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>abdominal</keyword>
  <keyword>aortic</keyword>
  <keyword>aneurysm</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm</mesh_term>
    <mesh_term>Aortic Aneurysm, Abdominal</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

